Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 20 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  2. US 8636988

    Composition for treatment of sunburned skin

    Doctor Essentials · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  3. US 8629260

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  4. US 8618259

    Polymer-factor VIII conjugate compositions

    Nektar Therapeutics · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  5. US 8614198

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  6. US 8613927

    High affinity human antibodies to human nerve growth factor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  7. US 8586711

    Polymer-factor IX moiety conjugates

    Nektar Therapeutics · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  8. US 8586363

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  9. US 8580923

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Northwestern University · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  10. US 8569379

    Use of rasagiline for the treatment of olfactory dysfunction

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  11. US 8569225

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  12. US 8557245

    Methods for treating bone cancer by administering a nerve growth factor antagonist antibody

    Regents of the University of Minnesota · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  13. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    ACADEMISCH MEDISCH CENTRUM · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  14. US 8519102

    Polymer Factor VIII moiety conjugates

    Nektar Therapeutics · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  15. US 8519103

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  16. US 8506947

    Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  17. US 8507653

    Factor IX moiety-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  18. US 8501466

    Vector

    The Pirbright Institute · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  19. US 8501740

    Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  20. US 8501688

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  21. US 8481289

    Triple acting antimicrobials that are refractory to resistance development

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  22. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  23. US 8450471

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 28, 2013 · Expires May 23, 2033

    granted

  24. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.